Nature's Sunshine Products Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Nature's Sunshine Products Inc. (NATR) has a 3-month relative strength percentile of 25 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.5%, relative volume 1.90×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
25 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
NATR is in a stage 3 topping pattern, week 2. Currently in a 81-day base; basing ADR 4.1% (broad 3.7%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: -8.2% / -3.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
NATR is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $10M notional. Top 3 carry $24M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $10M |
| IWMiShares Russell 2000 ETF | 0.01% | $10M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $880K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NATR Jan avg: 9.84% median: 8.78% win: 75% σ: 14.70% n: 4 2022-04-12 → 2026-05-29 | NATR Feb avg: 4.78% median: 3.70% win: 100% σ: 3.52% n: 4 2022-04-12 → 2026-05-29 | NATR Mar avg: -4.00% median: -9.57% win: 25% σ: 14.48% n: 4 2022-04-12 → 2026-05-29 | NATR Apr avg: 1.29% median: -1.83% win: 40% σ: 8.64% n: 5 2022-04-12 → 2026-05-29 | NATR May avg: -8.48% median: -21.23% win: 40% σ: 22.04% n: 5 2022-04-12 → 2026-05-29 | NATR Jun avg: 1.10% median: -2.98% win: 25% σ: 14.64% n: 4 2022-04-12 → 2026-05-29 (current) | NATR Jul avg: 2.10% median: 0.07% win: 50% σ: 8.22% n: 4 2022-04-12 → 2026-05-29 | NATR Aug avg: 3.56% median: 6.55% win: 50% σ: 20.05% n: 4 2022-04-12 → 2026-05-29 | NATR Sep avg: -6.42% median: -4.66% win: 0% σ: 6.53% n: 4 2022-04-12 → 2026-05-29 | NATR Oct avg: -2.44% median: -2.31% win: 50% σ: 9.47% n: 4 2022-04-12 → 2026-05-29 | NATR Nov avg: 20.52% median: 16.86% win: 75% σ: 25.41% n: 4 2022-04-12 → 2026-05-29 | NATR Dec avg: -2.61% median: -2.79% win: 50% σ: 6.69% n: 4 2022-04-12 → 2026-05-29 |